SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 30th, 2020 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 30, 2020, between Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Bellerophon Therapeutics, Inc.Exclusive Agency Agreement • March 30th, 2020 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2020 Company Industry Jurisdiction